Hyloris Pharmaceuticals Quote - HYL

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.00

Bid

5.90

Offer

6.24

Volume

99,840

5.64 Day's Range 6.38

2.89 52 Week Range 13.30

Market Cap

168M

Previous Close

5.34

Open

5.96

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

13,807

Shares Outstanding

28,000,000

Dividend Yield

PE Ratio

-10.92

Earnings Per Share (EPS)

-0.55

Revenue

4.21M

Net Profit

-15.38M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hyloris.com

Headquarters

Liege, Liege, Bel

Founded

Hyloris Pharmaceuticals SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker HYL. The last closing price for Hyloris Pharmaceuticals was 5.34 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 2.89 € to 13.30 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares in issue. The market capitalisation of Hyloris Pharmaceuticals is 149.52 € million. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -10.92.

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.4	7.14285714286	5.6	6.38	5.2	6367	5.30623874	DE
4	0.52	9.48905109489	5.48	6.38	4.86	8267	5.6663255	DE
12	0.02	0.334448160535	5.98	6.38	3.06	13807	5.28834991	DE
26	-5.7	-48.7179487179	11.7	11.7	2.89	18561	5.65907198	DE
52	-6.1	-50.4132231405	12.1	13.3	2.89	13305	7.64794796	DE
156	-11	-64.7058823529	17	19.1	2.89	7759	10.31138269	DE
260	-4.75	-44.1860465116	10.75	19.1	2.89	9136	11.15453279	DE

HYL - Frequently Asked Questions (FAQ)

What is the current Hyloris Pharmaceuticals share price?

The current share price of Hyloris Pharmaceuticals is 6.00 €

How many Hyloris Pharmaceuticals shares are in issue?

Hyloris Pharmaceuticals has 28,000,000 shares in issue

What is the market cap of Hyloris Pharmaceuticals?

The market capitalisation of Hyloris Pharmaceuticals is EUR 149.52M

What is the 1 year trading range for Hyloris Pharmaceuticals share price?

Hyloris Pharmaceuticals has traded in the range of 2.89 € to 13.30 € during the past year

What is the PE ratio of Hyloris Pharmaceuticals?

The price to earnings ratio of Hyloris Pharmaceuticals is -10.92

What is the cash to sales ratio of Hyloris Pharmaceuticals?

The cash to sales ratio of Hyloris Pharmaceuticals is 39.87

What is the reporting currency for Hyloris Pharmaceuticals?

Hyloris Pharmaceuticals reports financial results in EUR

What is the latest annual turnover for Hyloris Pharmaceuticals?

The latest annual turnover of Hyloris Pharmaceuticals is EUR 4.21M

What is the latest annual profit for Hyloris Pharmaceuticals?

The latest annual profit of Hyloris Pharmaceuticals is EUR -15.38M

What is the registered address of Hyloris Pharmaceuticals?

The registered address for Hyloris Pharmaceuticals is BOULEVARD PATIENCE ET BEAUJONC, LIEGE, LIEGE, 4000

What is the Hyloris Pharmaceuticals website address?

The website address for Hyloris Pharmaceuticals is www.hyloris.com

Which industry sector does Hyloris Pharmaceuticals operate in?

Hyloris Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALEMSEuropean Medical Solutions	6.70 € (37,122.22%)	40
CFNCofina SGPS SA	15.95 € (2,146.48%)	2.17k
DMSBSDiagnostic Medical Systems	0.003 € (50.00%)	52k
ALTROTronic s Microsystems	5.00 € (48.81%)	8
SEQUASequana medical NV	3.87 € (40.22%)	2.43M
EIFDSTour Eiffel DS	0.0184 € (-57.41%)	110.23k
ALCYBCybergun	0.0001 € (-50.00%)	112.66M
ALMEXMexedia SPA	5.00 € (-23.08%)	40
ALEUPEuroplasma	0.0413 € (-14.67%)	3.93M
MLFMVFarminveste	1.20 € (-14.29%)	1.36k
ATOAtos SE	0.0027 € (17.39%)	3.02B
ALCYBCybergun	0.0001 € (-50.00%)	112.66M
NEOENNeoen SA	39.83 € (0.73%)	81.42M
BCPBanco Comercial Portugues SA	0.4602 € (2.04%)	75.06M
ALHPIHopium SA	0.005 € (0.00%)	19.56M